Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How many clinical studies have evaluated the efficacy and safety of LYRICA as adjunctive therapy for partial onset seizures?

0
Posted

How many clinical studies have evaluated the efficacy and safety of LYRICA as adjunctive therapy for partial onset seizures?

0

A1: LYRICA has been studied in three 12-week, double-blind, placebo-controlled, multicenter clinical studies involving 1,052 adults with partial onset seizures. A highly refractory patient population was included in all LYRICA epilepsy studies. Patients who were enrolled had partial onset seizures with or without secondary generalization and were not adequately controlled on 1 to 3 concomitant antiepileptic drugs (AEDs).7,9,10 The mean duration of epilepsy in these 3 studies was 25 years, and the mean and median baseline seizure frequencies were 22.5 and 10 seizures per month. Approximately half of the patients were taking 2 concurrent AEDs at baseline. Up to 51% seizure frequency reduction with LYRICA 600 mg/day. In an additional TID study, seizure frequency was significantly reduced by up to 43% with LYRICA 600 mg/day. LYRICA reduced seizure frequency across the dose range by 50% or more in up to 51% of patients In this study, approximately 70% of patients were taking 2 or more AEDs

0

A1: LYRICA has been studied in three 12-week, double-blind, placebo-controlled, multicenter clinical studies involving 1,052 adults with partial onset seizures. A highly refractory patient population was included in all LYRICA epilepsy studies. Patients who were enrolled had partial onset seizures with or without secondary generalization and were not adequately controlled on 1 to 3 concomitant antiepileptic drugs (AEDs).7,9,10 The mean duration of epilepsy in these 3 studies was 25 years, and the mean and median baseline seizure frequencies were 22.5 and 10 seizures per month. Approximately half of the patients were taking 2 concurrent AEDs at baseline. Up to 51% seizure frequency reduction with LYRICA 600 mg/day. In an additional TID study, seizure frequency was significantly reduced by up to 43% with LYRICA 600 mg/day.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.